Further, the current analysis indicates that the specific effects of the VE-PTP inhibitor AKB-9785 in improving stroke outcome are mediated solely by restoring Tie2 signaling and are independent of VE-cadherin phosphorylation. This evidence concerns the gene CDH5 and stroke disorder.